SEATTLE, July 30, 2021, (MEDGADGET) — Global Cytotoxic Drugs Contract Manufacturing Market Analysis

Overview

Cytotoxic medications are highly active pharmaceuticals that are used to cure cancer. Contract production of cytotoxic drugs is a service provided by pharmaceutical and biotech manufacturing firms to cure chronic diseases such as cancer. New immuno-oncology treatments, such as antibody-drug conjugates, are being developed by cytotoxic drug manufacturers using HPAPIs (high potency active pharmaceutical ingredients). These contract manufacturing companies acquired technical experience, global scope, and the facilities needed to manage cytotoxic drugs effectively. This enables pharmaceutical and biotech companies to have new drugs in the shortest time possible.

The global contract manufacturing market for cytotoxic drugs was estimated at US$ 6,285.2 million in 2018 and is projected to grow at a 9.1% CAGR by 2027.

For Any Queries Get Solutions With PDF Sample: https://www.coherentmarketinsights.com/insight/request-sample/3175

Drivers

The global cytotoxic drugs contract manufacturing market is expected to grow in response to rising demand for specified therapies.

Manufacturers around the world are focusing on developing cytotoxic drugs and high potency active pharmaceutical ingredients in order to provide more specialized medicines, especially in the field of oncology. As per the IMS Institute of Healthcare Informatics, 586 oncology drugs were in circulation in 2016, with more than 70 experimental cancer therapies (for more than 20 tumor types) entering the market between 2010 and 2015.

One of the major factors projected to drive growth of the global cytotoxic drugs contract manufacturing market is increased investment by market players for facility expansion in order to increase market share. Piramal Pharma Solutions, a leading CDMO (Contract Development and Manufacturing Organization), announced the addition of a new wing to the Riverview facility in June 2019. HPAPIs with OELs (low occupational toxicity levels) are manufactured in the U.S. The total cost of upgrading the site was estimated to be about $10 million. Baxter BioPharma Solutions has expanded its cytotoxic contract manufacturing facility in Halle, Germany, in February 2013. The company’s production capacity has been increased to 1,750 square meters. Baxter BioPharma Solutions has added a new packaging line to its Halle/Westfalen, Germany facility in July 2013 to support its cytotoxic contract manufacturing services.

“Limited Time Offer”

Buy This Research Study Report With Flat US $2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/3175

Over the forecast period, main players are likely to follow further merger and partnership strategies, which is expected to fuel demand for cytotoxic drugs contract manufacturing. Merck KGaA (SAFC Pharma) purchased Sigma-Aldrich in November 2015 to expand its services, capabilities, global reach, and life sciences division.

Regional Analysis

Due to the rising prevalence of cancer in the region, the cytotoxic drugs contract manufacturing market in North America is projected to account for the largest market share over the forecast period. As per the National Cancer Institute, the number of new cancer cases each year in the U.S. is projected to rise to 23.6 million by 2030. Furthermore, the National Cancer Institute estimates that 16.8 million new cases of cancer were diagnosed in the U.S. in 2016, with 595,690 deaths due to the disease. By 2024, the global cancer population is projected to reach 19 million people.

Furthermore, due to the advent of government regulations and the rising prevalence of cancer in the region, Europe is projected to account for a substantial market share in the global cytotoxic drugs contract manufacturing market during the forecast period. As per the World Health Organization, about 4,229,662 new cancer cases were diagnosed in Europe in 2018. Furthermore, in 2016, the European Parliament launched new legislative guidelines on preventing workplace exposure to cytotoxic drugs, which was an effort intended to protect healthcare workers employed across the European Union. This was done because improper cytotoxic drug handling can lead to cancer, organ toxicity, reproductive issues, genetic damage, and birth defects.

Special Requirements?
We value your investment and offer customization as per your requirements.

Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/3175

Key Players

Key companies contributing in the global cytotoxic drugs contract manufacturing market are AbbVie Contract Manufacturing, CordenPharma International, BSP Pharmaceuticals, SAFC Pharma, Evonik Industries AG, Evotec, Piramal Group, Lonza Group, Dishman Group, Pierre Fabre Laboratories, WuXi AppTec Ltd., Novasep Holding SAS, Baxter Biopharma Solutions, Albany Molecular Research Inc., Catalent, Inc., and Cambrex Corporation.

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/cytotoxic-drugs-contract-manufacturing-market-2578

Table of Contents

1. Research Objectives and Assumptions
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Purview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snippet, By Production Scale
     • Market Snippet, By Form
     • Market Snippet, By Product Type
     • Market Snippet, By Region
   • Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
   • Impact Analysis
   • Epidemiology
   • Market Trends
   • Product Launch
   • Regulatory Scenario
   • PEST Analysis
   • Merger and Acquisition Scenario
   • Technological Advancements
4. Global Cytotoxic Drugs Contract Manufacturing Market, By Production Scale, 2016 – 2027, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2019 and 2027 (%)
     • Y-o-Y Growth Analysis, 2017 – 2027
     • Segment Trends
   • Industrial-scale
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
   • Pilot Scale
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
   • Laboratory Scale
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
5. Global Cytotoxic Drugs Contract Manufacturing Market, By Form, 2016 – 2027, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2019 and 2027 (%)
     • Y-o-Y Growth Analysis, 2017 – 2027
     • Segment Trends
   • Liquid
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
   • Solid
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
6. Global Cytotoxic Drugs Contract Manufacturing Market, By Product Type, 2016 – 2027, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2019 and 2027 (%)
     • Y-o-Y Growth Analysis, 2017 – 2027
     • Segment Trends
   • Oral
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
   • Intravenous
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
7. Global Cytotoxic Drugs Contract Manufacturing Market, By Region, 2016 – 2027, (US$ Mn)
   • Introduction
     • Market Share Analysis, By Region, 2016 and 2026 (%)
     • Y-o-Y Growth Analysis, For Regions, 2017–2026
   • North America
     • Market Size and Forecast, By Production Scale, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By Form, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
       • The U.S.
       • Canada
   • Latin America
     • Market Size and Forecast, By Production Scale, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By Form, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
       • Brazil
       • Mexico
       • Argentina
       • Rest of Latin America
   • Europe
     • Market Size and Forecast, By Production Scale, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By Form, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
       • Germany
       • The U.K.
       • France
       • Italy
       • Spain
       • Russia
       • Rest of Europe
   • Asia Pacific
     • Market Size and Forecast, By Production Scale, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By Form, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
       • China
       • India
       • Japan
       • Australia
       • South Korea
       • ASEAN
       • Rest of Asia Pacific
   • Middle East
     • Market Size and Forecast, By Production Scale, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By Form, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
       • GCC
       • Israel
       • Rest of the Middle East
   • Africa
     • Market Size and Forecast, By Production Scale, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By Form, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
     • Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Mn)
       • South Africa
       • Central Africa
       • North Africa
8. Competitive Landscape
   • Heat Map Analysis
   • Market Share Analysis
   • Analyst Views
9. Section
   • References
   • Research Methodology
   • About Us and Sales Contact

Other Exclusive Reports:

Fungal Otitis Externa Market Is Expected To Surpass US$ 206.94 Million By 2028

Central Nervous System Disorders Therapeutics Market To Surpass US$ 202.7 Million By 2028

Anti-Epileptic Drugs Market To Surpass US$ 7,344.9 Million By 2028

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837